Navigation Links
Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates
Date:7/29/2011

FRIDAY, July 29 (HealthDay News) -- Developed countries have seen a drop in breast cancer death rates in recent years, but a new international study suggests this trend is less about rising screening rates and more about the availability of increasingly effective treatments and improving health-care systems.

The finding stems from an analysis of World Health Organization (WHO) breast cancer data collected between 1980 and 2006, in which French, British and Norwegian researchers compared the screening and fatality rates of several Western European countries. The observations were presented online July 29 in the British Medical Journal.

"The contrast between the time differences in implementation of mammography screening and the similarity in reductions in mortality between the country pairs suggest that screening did not play a direct part in the reductions in breast cancer mortality," a team of researchers led by Philippe Autier, research director of the International Prevention Research Institute in Lyon, France, said in a journal news release.

To explore to what degree breast cancer screening rates appeared to be related to fatality rates, the authors chose six countries for points of comparison.

Northern Ireland was stacked up against the Republic of Ireland; the Netherlands was compared with Belgium/Flanders; and Sweden was examined alongside Norway.

The team noted that medical services and the prevalence of breast cancer death risk factors were comparable in each pairing. However, in the space of the study, the second country of each of the three groups was 10 to 15 years behind the first country in terms of their implementation of mammography screening protocols.

The results: Breast cancer death rates, which dropped across the board, were more or less similar in each country pairing, despite stark differences in screening histories.

For example, fatalities between 1989 and 2006 had plummeted by 29 percent in Northern Ireland, as compared with 26 percent in the Republic of Ireland.

The Netherlands registered a 25 percent drop, compared with a 20 percent to 25 percent drop in Belgium/Flanders, while the downward trend of 16 percent in Sweden compared with 24 percent in Norway.

In general terms, Autier's team also noted breast cancer death rates were not that different among women who had undergone almost no screening as compared with those who had been screened quite often.

And the biggest death rate drop seen overall was among women between the ages of 40 and 49, whether or not they had undergone screening.

Dr. Lauren Cassell, chief of breast surgery at Lenox Hill Hospital (affiliated with Northshore/LIJ) in New York City, cautioned that it's not clear that the current findings are easily generalizable to other nations.

"I'm not sure how well this finding would translate in comparison with the U.S.," she noted. "I suspect that we may be more aggressive in our screening protocols, and our health system is very different from the ones they looked at."

"And, in any case, I would certainly say that people should continue getting screened," Cassell stressed. "Because we still do know that catching any cancer at an earlier stage does translate into better outcomes and maybe less treatment. Because even if the end result is the same, and fatal, I certainly would like to have a cancer that could be treated with hormonal treatment and not chemotherapy, if possible."

More information

For more on breast cancer screening guidelines in the United States, visit the American Cancer Society.

-- Alan Mozes

SOURCE: BMJ, July 28, 2011, news release


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tamoxifen Wards Off Breast Cancers Return for More Than a Decade
2. Popular mammography tool not effective for finding invasive breast cancer
3. Breast density tied to specific types of breast cancer
4. Computer-Aided Mammography Doesnt Improve Breast Cancer Detection: Study
5. Greater Breast Density May Raise Cancer Risk
6. Johns Hopkins researchers discover how some breast cancers alter their sensitivity to estrogen
7. Hidden cancer cells not a factor in early-stage breast cancer survival rates
8. Vitamin D relieves joint, muscle pain for breast cancer patients
9. Lymph Node Test Doesnt Improve Breast Cancer Care, Study Finds
10. Scientists developing new therapy for HER2-positive breast cancer
11. Breast-feeding for 6 Months or More Protects Against Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates  
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
Breaking Medicine Technology: